Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Penglai Pharmaceutical is a Chinese pharmaceutical manufacturer specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a strong focus on therapeutic areas such as gastroenterology, cardiovascular disease, and anti-infectives. With multiple GMP-certified production lines, it serves as a significant supplier for both the domestic Chinese market and international clients. Its product portfolio includes well-known small molecules like Lansoprazole, Clopidogrel, and various statins. The company is recognized for its integrated capabilities in chemical synthesis and pharmaceutical formulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Penglai Pharmaceutical Plant.